Over 175 Crore COVID-19 Vaccines Administered

A new milestone of administering over 175 crore COVID-19 vaccine doses has been achieved by India. India's Covid-19 vaccination coverage has exceeded 175.03 crore.

A new milestone of administering over 175 crore COVID-19 vaccine doses has been achieved by India.

With the administration of more than 36.28 lakh COVID-19 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 175.03 crore, said Union Health Ministry on Saturday.

Indian Government Spends Rs. 250 Crore on Covid-19 Vaccine Research
Union Health Minister Mansukh Mandaviya said that the Central government has spent Rs. 250 crore on developing Covid-19 vaccine research.

‘Meanwhile, India has started showing declining Covid trends over the past few weeks. The nation on Saturday reported 14 per cent decline in fresh Covid infection at 22,270 cases, against 25,920 cases reported on previous day.’

As per the ministry, India’s vaccination coverage has exceeded 1,75,03,86,834 with 36,28,578 vaccine doses administered in the last 24 hours.

"New India, New Record. India has crossed historical figures of administering over 175 crore doses of vaccines. The World’s largest vaccination drive under PM Narendra Modi Ji’s leadership is touching new heights & accomplishing new feats every day," said Union Health Minister Mansukh Mandaviya in a tweet on Saturday.

Of the total doses administered so far, 1,04,00,492 health care workers received the first dose and 99,49,833 received the second dose. Total 40,22,962 precautionary doses have also been administered among healthcare workers so far.

MRNA COVID-19 Vaccines are Safe for Cancer Patients: Study
New study examined adverse effects of mRNA COVID-19 vaccination in patients with cancer and identified that they experienced no more, and no different, side effects.

A total of 1,84,07,428 front line workers were administered the first dose, 1,74,11,477 vaccine doses given as the second dose and 57,83,690 precautionary doses have been given to front line workers.

According to the health ministry, 55,00,31,980 vaccine doses were administered as the first dose and 43,42,94,627 vaccine doses were given as the second dose in the age group 18 to 44 years.

Efficacy of COVID-19 Vaccines Against Delta and Omicron Variants
Current COVID-19 vaccines provide robust protection against severe disease caused by both the Delta and Omicron variants.

Among 45-59 years age bracket, total 20,19,86,306 people have received the first dose and 17,80,23,333 have received the second dose. Also in over 60 plus population, 12,61,61,897 vaccine doses as first dose and 11,09,06,468 as the second dose have been administered so far. Total 88,93,489 precaution doses have also been given to the people over 60 years.

Source-IANS

Covid-19 Vaccine: Spikevax Gets Full Approval from US FDA
Spikevax, Moderna's Covid-19 vaccine has finally received full approval from the US Food and Drug Administration (FDA) for use in people ages 18 and older.